We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.

Srishti Nangia, M.D.

You are here

Srishti Nangia, M.D., is an Assistant Professor of Pediatrics at Weill Cornell Medicine and Assistant Pediatrician at NewYork-Presbyterian/Weill Cornell Medical Center.  She directs the Pediatric EMU and Pediatric EEG program.  She is board certified in Neurology with Special Qualifications in Child Neurology, Clinical Neurophysiology and Epilepsy. 

Dr. Nangia is Director of Pediatric EMU and Pediatric EEG, Program Director of Pediatric Clinical Neurophysiology Fellowship, and Medical Director of the Ketogenic Diet Program. She directs multiple clinics including the infantile spasms program and LGS clinics and works with the neurosurgeons of the Weill Cornell Brain and Spine Center in multidisciplinary clinics for presurgical evaluation of refractory epilepsy patients, post-surgery follow-up, tumoral epilepsy and TSC. She is a member of Child Neurology Society, American Epilepsy Society, American Clinical Neurophysiology Society and American Academy of Neurology. She is also on the TS Alliance's Professional Advisory Board. 

Dr. Nangia graduated Phi Beta Kappa and summa cum laude with a BA in Psychology at Barnard College, Columbia University, then went on to earn her MD from SUNY Downstate Medical Center. She completed a pediatric residency at Northwell Health (formerly Schneider Children’s Hospital, LIJ), followed by a two-year combined pediatric and adult clinical neurophysiology fellowship at NYP/Weill Cornell Medical Center. 

Dr. Nangia's clinical and research interests include early onset epilepsy, infantile spasms, Lennox Gastaut Syndrome (LGS), Doose Syndrome/epileptic encephalopathy, tuberous sclerosis complex (TSC), genetic epilepsies, Jeavon's Syndrome, epilepsy surgery, ketogenic diet, cannabidiol and use of EEG to identify epilepsy syndromes.